SUGAMMADEX LAPL sugammadex (as sodium) 500 mg/5 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

sugammadex lapl sugammadex (as sodium) 500 mg/5 ml solution for injection vial

lupin australia pty limited - sugammadex sodium, quantity: 544 mg (equivalent: sugammadex, qty 500 mg) - injection - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - reversal of neuromuscular blockade induced by rocuronium or vecuronium in patients 2 years of age and older.

SUGAMMADEX LUPIN sugammadex (as sodium) 500 mg/5 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

sugammadex lupin sugammadex (as sodium) 500 mg/5 ml solution for injection vial

lupin australia pty limited - sugammadex sodium, quantity: 544 mg (equivalent: sugammadex, qty 500 mg) - injection - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - reversal of neuromuscular blockade induced by rocuronium or vecuronium in patients 2 years of age and older.

SUGAMMADEX KABI sugammadex (as sodium) 200 mg/2 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

sugammadex kabi sugammadex (as sodium) 200 mg/2 ml solution for injection vial

fresenius kabi australia pty ltd - sugammadex sodium, quantity: 217.6 mg (equivalent: sugammadex, qty 200 mg) - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid - reversal of neuromuscular blockade induced by rocuronium or vecuronium in patients 2 years of age and older.

SUGAMMADEX KABI sugammadex (as sodium) 500 mg/5 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

sugammadex kabi sugammadex (as sodium) 500 mg/5 ml solution for injection vial

fresenius kabi australia pty ltd - sugammadex sodium, quantity: 544 mg (equivalent: sugammadex, qty 500 mg) - injection, solution - excipient ingredients: hydrochloric acid; sodium hydroxide; water for injections - reversal of neuromuscular blockade induced by rocuronium or vecuronium in patients 2 years of age and older.

SUGAMMADEX-REDDY'S sugammadex (as sodium) 200 mg/2 mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

sugammadex-reddy's sugammadex (as sodium) 200 mg/2 ml injection vial

dr reddys laboratories australia pty ltd - sugammadex sodium, quantity: 217.6 mg (equivalent: sugammadex, qty 200 mg) - injection, solution - excipient ingredients: hydrochloric acid; sodium hydroxide; water for injections - reversal of neuromuscular blockade induced by rocuronium or vecuronium in patients 2 years of age and older.

TE-SUGAMMADEX sugammadex (as sodium) 200 mg/2 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

te-sugammadex sugammadex (as sodium) 200 mg/2 ml solution for injection vial

teva pharma australia pty ltd - sugammadex sodium, quantity: 217.6 mg (equivalent: sugammadex, qty 200 mg) - injection, solution - excipient ingredients: hydrochloric acid; sodium hydroxide; water for injections - reversal of neuromuscular blockade induced by rocuronium or vecuronium in patients 2 years of age and older.

BRIDION- sugammadex injection, solution United States - English - NLM (National Library of Medicine)

bridion- sugammadex injection, solution

medical purchasing solutions, llc - sugammadex sodium (unii: erj6x2mxv7) (sugammadex - unii:361lpm2t56) - bridion ® is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adults undergoing surgery. bridion is contraindicated in patients with known hypersensitivity to sugammadex or any of its components. hypersensitivity reactions that occurred varied from isolated skin reactions to serious systemic reactions (i.e., anaphylaxis, anaphylactic shock) and have occurred in patients with no prior exposure to sugammadex [see warnings and precautions (5.1), adverse reactions (6)] . risk summary there are no data on bridion use in pregnant women to inform any drug-associated risks. in animal reproduction studies, there was no evidence of teratogenicity following daily intravenous administration of sugammadex to rats and rabbits during organogenesis at exposures of up to 6 and 8 times, respectively, the maximum recommended human dose (mrhd) of 16 mg/kg. however, there was an increase in the incide

SUGAMMADEX SCIGEN SOLUTION FOR INJECTION 100MGML Singapore - English - HSA (Health Sciences Authority)

sugammadex scigen solution for injection 100mgml

scigen pte. ltd. - sugammadex sodium eqv sugammadex - injection, solution - sugammadex sodium eqv sugammadex 100mg/ml

BRIDION Israel - English - Ministry of Health

bridion

merck sharp & dohme (israel - 1996) company ltd, israel - sugammadex - solution for injection - sugammadex 100 mg/ml - sugammadex - sugammadex - reversal of neuromuscular blockade induced by rocuronium or vecuronium.

Sugammadex Anfarm 100 mg/mL solution for injection (2ml vial) Malta - English - Medicines Authority

sugammadex anfarm 100 mg/ml solution for injection (2ml vial)

anfarm hellas s.a. 4 achaias str. & trizinias 14564 kifissia, attiki, greece - solution for injection - sugammadex 200 mg/2ml - all other therapeutic products